Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Triton acquires Bravida ASA
Mandate

Triton acquires Bravida ASA

February 19, 2007

Triton is acquiring roughly a total of 98 percent of the shares in Bravida ASA from Telenor ASA, Telenor Installation Holding AS, Sampo Life Insurance Company, Investment AB Latour, Stark II BV, Procuritas Capital Partners II LP, Procuritas Capital Partners IIB LP, SäkI AB and Baring European Fund (GP) LP. The Bravida group is the Nordic region's largest installation and service company with 8000 employees in Norway, Sweden and Denmark and sales of roughly SEK 9.5 billion. Bravida supplies solutions for the electricity, AC power, ventilation, security, service and property management industries, both the private and public sectors, and is represented in more that 150 locations in the Nordic region.

The legal advisor for Triton was the law firm of Vinge, with managing partner Christina Kokko handling mergers and acquisitions, and Mikael Ståhl for financing, who was assisted by Tom Zachrisson, Matti Scheffer, Peter Svanqvist, Johan Steen, Anna Elm and Kanja Berg.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025